Michael F Mahoney Boston Scientific Corp (BSX) insider trading activity

Michael F Mahoney is Chairman, President & CEO of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 1.48 Million shares of BSX, which is worth approximately $147 Million. The most recent transaction as insider was on Feb 16, 2023, when has been sold 16,264 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.48M

10.67% 3M change

11.77% 12M change

Total Value Held $147 Million

Michael F Mahoney Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 16 2023	BUY Exercise of conversion of derivative security	-	16,264 Added 0.88%	1,829,415 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$387,115 $47.29 p/Share	8,186 Reduced 0.45%	1,813,151 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	-	18,457 Added 1.0%	1,821,337 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$1,044,591 $46.27 p/Share	22,576 Reduced 1.24%	1,802,880 Common Stock
Jan 01 2023	BUY Exercise of conversion of derivative security	-	57,791 Added 3.07%	1,825,456 Common Stock
Nov 07 2022	SELL Open market or private sale	$5,280,959 $41.97 p/Share	125,827 Reduced 6.65%	1,767,665 Common Stock
Nov 07 2022	BUY Exercise of conversion of derivative security	$1,288,468 $10.24 p/Share	125,827 Added 6.23%	1,893,492 Common Stock
Oct 03 2022	SELL Open market or private sale	$4,950,034 $39.34 p/Share	125,827 Reduced 6.65%	1,767,665 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$1,288,468 $10.24 p/Share	125,827 Added 6.23%	1,893,492 Common Stock
Sep 06 2022	SELL Open market or private sale	$5,094,776 $40.49 p/Share	125,828 Reduced 6.65%	1,767,665 Common Stock
Sep 06 2022	BUY Exercise of conversion of derivative security	$1,288,479 $10.24 p/Share	125,828 Added 6.23%	1,893,493 Common Stock
Aug 30 2022	SELL Bona fide gift	-	365,457 Reduced 17.13%	1,767,665 Common Stock
Aug 08 2022	SELL Open market or private sale	$5,155,173 $40.97 p/Share	125,828 Reduced 5.57%	2,133,122 Common Stock
Aug 08 2022	BUY Exercise of conversion of derivative security	$1,288,479 $10.24 p/Share	125,828 Added 5.28%	2,258,950 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$359,102 $44.17 p/Share	8,130 Reduced 0.38%	2,133,122 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	18,330 Added 0.85%	2,141,252 Common Stock
Feb 21 2022	SELL Payment of exercise price or tax liability	$317,508 $42.55 p/Share	7,462 Reduced 0.35%	2,122,922 Common Stock
Feb 21 2022	BUY Exercise of conversion of derivative security	-	16,825 Added 0.78%	2,130,384 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$307,764 $42.55 p/Share	7,233 Reduced 0.34%	2,113,559 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	16,307 Added 0.76%	2,120,792 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$348,251 $42.83 p/Share	8,131 Reduced 0.38%	2,104,485 Common Stock
Feb 17 2022	BUY Exercise of conversion of derivative security	-	18,333 Added 0.86%	2,112,616 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$360,266 $44.01 p/Share	8,186 Reduced 0.39%	2,094,283 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	18,457 Added 0.87%	2,102,469 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$1,000,192 $42.48 p/Share	23,545 Reduced 1.12%	2,084,012 Common Stock

Also insider at

BAX

BAXTER INTERNATIONAL INC Healthcare

Director

CVS

CVS HEALTH Corp Healthcare

Director

MFM